MedPath

Evaluation of the preoperative effect of Mirtazapine administration on reducing postoperative pain, in hospitals affiliated with Islamic Azad University of Tehran in 2023

Phase 3
Recruiting
Conditions
postoperative pain.
Registration Number
IRCT20221015056178N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
76
Inclusion Criteria

Patients who are candidates for surgery
Insensitivity to Mirtazapine
Age between 25 and 50 years
BMI between 20 and 25
ASA one or two
Patient consent to conduct a clinical trial

Exclusion Criteria

Surgeries greater than an hour
Emergency surgeries
Pregnant women or the possibility of pregnancy
Diabetic, cardiac, pulmonary and neurological patients
Drug addiction

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of postoperative pain. Timepoint: 2, 6 and 12 hours after leaving the operating room. Method of measurement: Visual Analogue Scale (facial experience).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath